Conference
Phase II study of the angiogenesis inhibitor AZD2171 in first line, progressive, unresectable, advanced metastatic renal cell carcinoma (RCC): A trial of the PMH Phase II Consortium
Authors
Sridhar SS; Hotte SJ; Mackenzie MJ; Kollmannsberger C; Haider MA; Pond GR; Chen EX; Srinivasan R; Ivy SP; Moore MJ
Volume
25
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2007
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X